Biogen Inc (FRA:IDP)
€ 211.3 -1.2 (-0.56%) Market Cap: 30.76 Bil Enterprise Value: 36.15 Bil PE Ratio: 29.38 PB Ratio: 2.24 GF Score: 68/100

Biogen Inc at Cowen Healthcare Conference (Virtual) Transcript

Mar 01, 2021 / 03:20PM GMT
Release Date Price: €228.3 (+2.01%)
Philip M. Nadeau
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst

Good morning, and welcome once again to Cowen and Company's hopefully only virtual health care conference. I'm Phil Nadeau, Biotech Analyst here at Cowen, and it's my pleasure to moderate a fireside chat with Biogen. We have Michel Vounatsos, the CEO of Biogen with us today, as well as AL Sandrock, Executive Vice President of R&D.

Questions & Answers

Philip M. Nadeau
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst

So maybe over to you for the first question. Can you discuss your vision for Biogen over the next 5 years? How is the company going to create shareholder value? And what do you think differentiates Biogen as an investment versus other large-cap biotechs?

Michel Vounatsos
Biogen Inc. - CEO & Director

Thank you, Phil. And before we begin, I would like to make -- to point out that I will be making some forward-looking statements, which are based on current

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot